COMP <GO>
ALGN vs LLY // RSI-14 & 200D SMA MOMENTUM
Align Technology Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: ALGN 5
— LLY 10
▲ RSI-14 & 200D SMA MOMENTUM LEADER: LLY
LAST: $149.89 (-2.49%) • MKT CAP: $10.92B
rsi-technicals
49.8
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
rsi-technicals
77.9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALGN VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALGN | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 67.20% | 83.64% | -16.44 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.10% | 32.36% | -21.26 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 36.4x | -19.42 | ALGN | /valuation <GO> |
| Free Cash Flow Yield | 4.49% | 2.30% | +2.19 | ALGN | /fcf-yield <GO> |
| Operating Margin | 13.50% | 40.21% | -26.71 | LLY | /operating-margins <GO> |
| Net Profit Margin | 10.20% | 31.90% | -21.70 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 0.90% | 45.51% | -44.61 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.62 | 9.29 | -4.67 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.77% | -0.17 | ALGN | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 49.8 | 77.9 | -28.07 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.51 | +0.39 | ALGN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.7x | 26.3x | -1.55 | ALGN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.92B | $1.33T | -$1.32T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALGN REV | LLY REV | ALGN GROSS % | LLY GROSS % | ALGN FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.03B | $65.18B | 67.2% | 83.0% | $490.8M | $16.81B |
| FY 2024 | $4.00B | $45.04B | 70.0% | 81.3% | $622.7M | $8.82B |
| FY 2023 | $3.86B | $34.12B | 44.0% | 79.3% | $612.0M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALGN // BETA 0.90
LLY // BETA 0.51